Journal for Clinical Studies – by Greg Killian
Bogged down by recruiting challenges and impaired by inconvenient travel distances, almost half of clinical trial sites miss enrollment targets, with nearly half of patients dropping out before study completion. Because of these issues, clinical trials incur $600K to $8M in potential daily losses. Accordingly, the pharmaceutical industry is quickly pivoting away from “site-centric” to “patient-centric” clinical trials, not only to curb losses but to improve results and outcomes. Through process and technical innovation including remote monitoring, advanced analytics, and agile ways of working, digital alternatives have the potential to help reduce time to market by 500 days and reduce development costs by 25%. More accessible, affordable, and faster than traditional models, digital and decentralized trials can allow for greater clinical diversity, seamless coordination, better trial process control and enhanced patient progress tracking.
To read the full article, click here (pp. 12-14).
To explore our latest work in the healthcare industry, click here.
To learn about our latest content on the cloud, click here.
Discover how we deliver innovative strategies and technology solutions for global life sciences companies here.